Genomics
Genomics has the potential to unlock entirely new approaches to healthcare, from prevention to diagnosis to treatment. London’s thriving genomics ecosystem brings together world-leading government backed research and innovative commercial enterprises to deliver the genomics revolution.
8% year-on-year growth
in genomics companies for the past five years
$1.2bn
funding raised by genomics companies in the past ten years
75
active genomics companies in London
>120,000 genomes
sequenced by Genomics England, headquartered in London’s Canary Wharf
Success stories:
100,000 Genomes Project
The 100,000 Genomes Project was a world-first study to sequence and study the role our genes play in health and disease. 18.5% of data turned into actionable findings, 85K+ participants, 120,000+ genomes sequenced. Genomics England, itself based in London, is now running a successor project, the Newborn Genomes Programme
Success stories:
Queen Mary University of London
Two QMUL research papers in genomic medicine have been selected in the top 10 most important advances in applying genomic medicine to clinical care in 2022. Researchers found that genome sequencing may be the method of choice for detecting repeat expansion disorders, and the 100,000 genomes project showed that genome sequencing led to a substantial increase in diagnosis.
Success stories:
Francis Crick Institute
Researchers at the Francis Crick Institute described how changes to cancer cell DNA are enabling them to anticipate how those cells will behave in the future, in the first long-term study of how lung cancer evolves. The TRACERx study, funded by Cancer Research UK, involved more than 800 patients in clinical trials, and will significantly impact how cancer patients are diagnosed and treated.
Programmes & initiatives
- The London Genomics Network connects and supports genomics scientists in London and beyond to provide a community, promote work and services, share knowledge, provide training, and hold regular events for genomic scientists in London. Learn more
- For other relevant support programmes and funding see Support.
MORE EXPERTISE
Metabolic disease
Mental health & neurodegeneration
Immunology & infectious disease
Cardiovascular & respiratory
Diagnostics & biomarkers
Digital health
Cell & gene therapy
